Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00262860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: bortezomib
DRUG: gemcitabine hydrochloride

Sponsor

University of Rochester